Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Ema ofev loss of exclusivity?Mounjaro how long patent?Linagliptin 5 mg price in uae?Kadcyla manufacturing conjugation process?Where to look for historical market exclusivity of mirena in us market?
See the DrugPatentWatch profile for pulmozyme
FDA approval for Pulmozyme (dornase alfa) was May 9, 1996 [1].
Pulmozyme (dornase alfa) is used to help improve lung function in people with cystic fibrosis by reducing the viscosity of mucus in the airways [1].
You can verify the approval date in DrugPatentWatch’s drug record for Pulmozyme (dornase alfa) [1].
1
Other Questions About Pulmozyme :